Drosophila Myc restores immune homeostasis of Imd pathway via activating miR-277 to inhibit imd/Tab2.

Ruimin Li,Hongjian Zhou,Chaolong Jia,Ping Jin,Fei Ma
DOI: https://doi.org/10.1371/journal.pgen.1008989
IF: 4.5
2020-01-01
PLoS Genetics
Abstract:Author summary Innate immunity is the first line of defense against pathogenic microorganisms. Both overactivation and depression of immune response are detrimental to the organism. It is indispensable to regulate the duration and intensity of immune response. In this work, we find thatDrosophilaMyc (dMyc) as a transcription factor activates the transcription of miR-277 to negatively regulate the Imd pathway via inhibiting the expression ofimd/Tab2gene in the middle and later stage ofDrosophilainnate immune. dMyc is required to restoreDrosophilaimmune homeostasis for the survival of flies upon infection. Since dMyc is well conserved in animals, our findings will be important in understanding the complex regulatory mechanisms of innate immune responses in animals. DrosophilaMyc (dMyc), as a broad-spectrum transcription factor, can regulate the expression of a large number of genes to control diverse cellular processes, such as cell cycle progression, cell growth, proliferation and apoptosis. However, it remains largely unknown about whether dMyc can be involved inDrosophilainnate immune response. Here, we have identified dMyc to be a negative regulator ofDrosophilaImd pathway via the loss- and gain-of-function screening. We demonstrate that dMyc inhibitsDrosophilaImd immune response via directly activatingmiR-277transcription, which further inhibit the expression ofimdandTab2-Ra/b. Importantly, dMyc can improve the survival of flies upon infection, suggesting inhibitingDrosophilaImd pathway by dMyc is vital to restore immune homeostasis that is essential for survival. Taken together, our study not only reports a new dMyc-miR-277-imd/Tab2 axis involved in the negative regulation ofDrosophilaImd pathway, and provides a new insight into the complex regulatory mechanism ofDrosophilainnate immune homeostasis maintenance.
What problem does this paper attempt to address?